Download original image
Fig. 2. (A) Urinary monocyte chemoattractant protein-1 (MCP-1) and (B) neutrophil gelatinase-associated lipocalin (NGAL) concentrations by chronic kidney disease (CKD) stage. 1, CKD stage 1 (glomerular filtration rate [GFR]>90 mL/min/1.73 m2); 2, CKD stage 2 (60≤GFR<90 mL/min/ 1.73 m2); 3, CKD stage 3 (30≤GFR<60 mL/min/1.73 m2). At CKD stage 1, MCP-1 was (GFR>90 mL/min/1.73 m2) 0.33 pg/mL (interquartile range [IQR], 0.21 to 1.35) and NGAL was 50.0 pg/mL (IQR, 49.4 to 85.5); at CKD stage 2, MCP-1 was (60≤GFR<90 mL/min/1.73 m2) 0.61 pg/mL (IQR, 0.12 to 4.20) and NGAL was 62.2 pg/mL (IQR, 50.0 to 151.0); and at CKD stage 3, MCP-1 was (30≤GFR<60 mL/min/1.73 m2) 4.47 pg/mL (IQR, 0.23 to 10.81) and NGAL was 126.45 pg/mL (IQR, 57.5 to 205.15).
J Obes Metab Syndr 2024;33:360~366 https://doi.org/10.7570/jomes24002
© JOMES